Sex and gender disparities in bladder cancer have long been a subject of interest to the
cancer research community, wherein men have a 4 times higher incidence rate than women …

Muscle-invasive bladder cancer (MIBC) is associated with high rates of recurrence and poor
prognosis despite aggressive treatment. Neoadjuvant chemotherapy before radical …

Purpose: There are conflicting reports on outcome trends following radical cystectomy (RC)
for bladder cancer. Materials and Methods: Evolution of modern bladder cancer …

Bladder cancer is a complex disease with variable prognosis. Recent investigations into the
molecular landscape of bladder cancer have revealed frequent genetic alterations and …

Neoadjuvant cisplatin-based chemotherapy (NACC) followed by radical cystectomy is the
standard treatment for localized muscle-invasive bladder cancer (MIBC). Patients who …

Female patients with bladder cancer (BCa) have had more advanced disease than their
male counterparts at diagnosis and have experienced worse oncologic outcomes. However …

Background: We aimed to provide a comprehensive literature review on the best practice
management of patients with nonmetastatic muscle-invasive bladder cancer (MIBC) using …

Background The purpose of this study was to analyze trends of bladder cancer (BC) stages
and incidence in Europe and the United States (US). Materials and Methods Tumor stages …

Simple Summary This review presents the current status of diagnostic and treatment options
in bladder cancer (BCa) patients with clinically positive lymph nodes (cN+). There is no …

Background Guidelines recommend neoadjuvant chemotherapy (NAC) for the treatment of
nonmetastatic muscle-invasive bladder cancer (MIBC). NAC is, however, underutilized in …